Introduction {#s1}
============

Hypertension in adults has been one of the major contributors to cardiovascular disease burden worldwide. It is estimated that nearly 10.7 million deaths and 211.8 million disability adjusted life-years were due to hypertension worldwide in 2015 ([@B1]). Notably, pediatric elevated blood pressure (BP) tends to track into adulthood ([@B2]) and it is associated with a series of early target organ damages in childhood ([@B3]), which can increase the risk of cardiovascular diseases later in life. Therefore, recognition and control of elevated BP at an early age may be an important strategy for reducing the hypertension-induced cardiovascular disease burden.

BP in children may vary a lot due to several potential reasons, such as the "white coat effects" and environmental factors (e.g., temperature and noise), which may cause transient elevated BP. Therefore, hypertension in children defined based on the BP measured at one single visit may overestimate the true prevalence. Indeed, clinical practice guidelines recommended that hypertension in children and adolescents should be defined based on elevated BP on at least three separate occasions ([@B4]--[@B6]). Up to now, several studies from western pediatric populations have assessed the prevalence of hypertension based on this recommendation ([@B7], [@B8]). However, few are from Chinese children and adolescents ([@B9], [@B10]). In addition, different populations may have different growth and development patterns and different exposures to lifestyle factors.

Adiposity has been shown to be an independent risk factor for elevated BP in children. However, most analyses were conducted using body mass index (BMI) as the indicator to assess weight status, which cannot distinguish fat distribution. Waist circumference (WC) and waist-to-height ratio (WHtR) are indicators of abdominal obesity that can better assess the distribution of the visceral adipose tissue ([@B11]).

Thus, based on a school-based, cross-sectional survey conducted in Jinan, China, we aimed to estimate the true prevalence of hypertension among Chinese children and adolescents aged 6--17 years. In addition, we examined the relationship between elevated BP and excess weight defined in three ways.

Materials and Methods {#s2}
=====================

Study Population
----------------

This study was conducted in four schools in urban region of Jinan, China between September 2012 and September 2014. The four public schools, including two primary schools, one junior high school and one senior high school, were chosen using convenient cluster sampling method. All students from the selected schools were invited to participate in the survey. A standard questionnaire, including demographic information, family history of hypertension, puberty status, and lifestyle factors, was finished by the students and/or their parents. Physical examinations (i.e., height, weight, WC, and BP) were conducted by trained research staff according to a standard protocol. A total of 7,832 students were included in the present study after excluding those with missing information on age, sex, height, weight, WC, and BP. Signed informed consent was obtained from all students and their guardians. Ethical approval was obtained from the Ethics Committee of the Capital Institute of Pediatrics in Beijing, China.

BP Measurements and Definitions
-------------------------------

BP was measured by trained examiners with a clinically validated electronic device (OMRON HEM-7012) ([@B12]). After at least 10 min of rest, BP was measured on the right arm supported at the level of heart, in a sitting position with the back supported and feet flat on the floor. The mid-arm circumference was measured and appropriate cuff size was chosen (i.e. small, normal, or large cuff for a mid-arm circumference of 13.0--21.9, 22.0--31.9, or 32.0--42.0 cm, respectively). Three consecutive BP measurements were taken with at least 1 min apart. If the difference between any two of the three BP readings was more than 5 mmHg, then a fourth BP measurement was conducted. Mean value of the last two readings was used for data analysis.

Elevated BP was defined if systolic BP (SBP) and/or diastolic BP (DBP) ≥age- and sex-specific 95th percentiles of the Chinese BP references ([@B13]). Participants with elevated BP at the first visit underwent a second visit at least 2 weeks later. If elevated BP persisted at the second visit, a third visit was conducted at least another 2 weeks later, according to the same procedures. Those with elevated BP at all the three visits were identified as hypertensive ([@B4]--[@B6]). The flow chart of the BP screening procedures is shown in [Figure 1](#F1){ref-type="fig"}. One hundred thirteen of 1,347 children and adolescents with elevated BP at the first visit and 97 of 662 children and adolescents with sustained elevated BP at the second visit were lost to follow-up for some reasons, such as refusal, absence from school, or having a disease. We compared the baseline characteristics between followed-up participants and those lost to follow-up and we found no significant differences (data not shown).

![The flow chart of blood pressure screening procedures.](fped-07-00307-g0001){#F1}

Adiposity Measurements and Definitions
--------------------------------------

Weight was measured twice in light clothes and without shoes using an electronic scale, and was approximated to 0.1 kg. Height was also measured twice and approximated to 0.1 cm. The mean of two measures was used for analysis. BMI was calculated as the weight divided by the height squared (kg/m^2^). Normal weight, overweight, and obesity were defined based on the age- and sex-specific BMI cutoffs for Chinese children and adolescents ([@B14]). WC was also measured twice and approximated to 0.1 cm using a standard tape. Extend the tape around the waist in a horizontal plane at the level of 1 cm above the umbilicus. Central overweight and obesity were defined according to the age- and sex-specific WC cutoffs of Chinese children and adolescents ([@B15]). WHtR was calculated as the ratio of WC and height. WHtR ≥0.50 was used to define central obesity ([@B16]).

Covariates
----------

The collected information includes age, sex, birth weight, puberty status, parental history of hypertension, and parental education levels. Puberty status was dichotomized based on whether they had menarche for girls or spermatorrhoea for boys. Parental history of hypertension (yes vs. no) was obtained from both father and mother using the following question: Have you ever been told by a physician to be hypertensive or taking anti-hypertensive drugs currently? Parental education levels were categorized into primary school, high school, college or university.

Statistical Analysis
--------------------

Data were analyzed with SAS, version 9.3 (SAS Institute, Cary, NC, USA). Quantitative variables were presented as mean ± standard deviation (or standard error). The differences in quantitative variables between groups were compared by covariance analysis adjusted for age and sex (or BMI), and linear regression analysis was used to test trends. Categorical variables were expressed as percentages and the differences between groups were compared by chi-square test and Cochran-Armitage analysis was used for trend tests. Binary logistic regression analysis was used to assess the relationship between adiposity measures and hypertension, with adjustment of potential covariates. Odds ratios (ORs) with the corresponding 95% confidence intervals (CIs) were calculated. Two-sided *p* \< 0.05 was considered as statistically significant.

Results {#s3}
=======

Characteristics of the Participants Across Three Different Visits
-----------------------------------------------------------------

A total of 7,832 students (boys: 52.0%), aged 6--17 years, were included at the first visit, 1,234 (boys: 61.7%) at the second visit, and 565 (boys: 68.5%) at the third visit. Characteristics of the participants across the three separate visits are presented in [Table 1](#T1){ref-type="table"}. Boys had higher height, weight, BMI, WC, WHtR, and higher prevalence of general and central obesity than girls at each visit (all *p* \< 0.001). Of note, the prevalence of obesity was particularly high in both genders at the third visit, with the estimates reaching 59.7, 66.6, and 55.0%, respectively, based on different adiposity measures including BMI, WC and WHtR.

###### 

Characteristics of the participants across three different visits.

                          **First visit**   **Second visit**   **Third visit**                                                                                                           
  ----------------------- ----------------- ------------------ ----------------- --------- ------------- ------------- ------------- --------- ------------- ------------- ------------- ---------
  ***N***                 7,832             4,076              3,756                       1,234         761           473                     565           387           178           
  Age (years)             11.3 ± 0.1        11.3 ± 0.1         11.3 ± 0.1        0.404     12.2 ± 0.1    12.4 ± 0.1    11.8 ± 0.2    0.012     12.5 ± 0.1    12.6 ± 0.2    12.0 ± 0.3    0.044
  Height (cm)             151.0 ± 0.1       153.1 ± 0.1        148.8 ± 0.1       \<0.001   155.7 ± 0.2   158.7 ± 0.3   152.7 ± 0.4   \<0.001   156.5 ± 0.4   159.4 ± 0.4   153.6 ± 0.6   \<0.001
  Weight (kg)             47.6 ± 0.1        50.8 ± 0.2         44.3 ± 0.2        \<0.001   59.1 ± 0.5    64.4 ± 0.6    53.7 ± 0.7    \<0.001   62.9 ± 0.7    68.1 ± 0.8    57.7 ± 1.2    \<0.001
  BMI (kg/m^2^)           20.1 ± 0.1        20.8 ± 0.1         19.4 ± 0.1        \<0.001   23.5 ± 0.1    24.6 ± 0.2    22.3 ± 0.2    \<0.001   24.8 ± 0.2    25.8 ± 0.3    23.7 ± 0.4    \<0.001
  WC (cm)                 67.6 ± 0.1        70.7 ± 0.2         64.6 ± 0.2        \<0.001   75.5 ± 0.4    80.0 ± 0.5    71.0 ± 0.6    \<0.001   78.6 ± 0.6    83.1 ± 0.6    74.2 ± 0.9    \<0.001
  WHtR                    0.4 ± 0.1         0.5 ± 0.1          0.4 ± 0.1         \<0.001   0.5 ± 0.1     0.5 ± 0.1     0.5 ± 0.1     \<0.001   0.5 ± 0.1     0.5 ± 0.1     0.5 ± 0.1     \<0.001
  **BMI categories,%**                                                                                                                                                                   
     Normal weight        59.1              53.3               65.3              \<0.001   28.7          23.3          37.4          \<0.001   17.5          12.9          27.5          \<0.001
     Overweight           21.0              21.7               20.3                        24.6          23.9          25.8                    22.8          23.3          21.9          
     Obesity              19.9              25.1               14.4                        46.7          52.8          36.8                    59.7          63.8          50.6          
  **WC categories,%**                                                                                                                                                                    
     Normal WC            52.3              48.4               56.5              \<0.001   25.0          20.9          31.5          \<0.001   16.1          12.7          23.6          0.003
     Central overweight   19.9              19.4               20.4                        19.0          18.3          20.1                    17.4          17.1          18.0          
     Central obesity      27.9              32.2               23.1                        56.1          60.8          48.4                    66.6          70.3          58.4          
  **WHtR categories,%**                                                                                                                                                                  
     Normal WHtR          80.9              73.7               88.8              \<0.001   57.0          48.5          70.6          \<0.001   45.0          38.8          58.4          \<0.001
     Central obesity      19.1              26.3               11.2                        43.0          51.5          29.4                    55.0          61.2          41.6          

*Data are shown as mean ± standard error*.

*Covariance analysis adjusted for sex and age if appropriate*.

Prevalence of Elevated BP Across Three Different Visits
-------------------------------------------------------

The levels of SBP and DBP increased greatly across the three separate visits, and the similar trends were found in the subgroups by sex and age ([Table 2](#T2){ref-type="table"}). [Table 3](#T3){ref-type="table"} shows the prevalence of elevated BP across three separate occasions among Chinese children and adolescents by age and sex. The prevalence of elevated BP was 17.2, 8.6, and 4.9% at the first, second and third visit, respectively. There was a downward trend in the prevalence of elevated BP over three repeated visits (*p* for trend\<0.001). There were similar trends in elevated SBP and DBP across three visits, with the prevalence being 15.3, 8.2, and 4.8%, respectively, for elevated SBP and 6.0, 2.5, and 1.2%, respectively, for elevated DBP.

###### 

Mean blood pressure values across three different visits.

                 **Visit**       **SBP, mmHg**   **DBP, mmHg**
  -------------- --------------- --------------- ---------------
  Total          First           109.5 ± 0.1     64.3 ± 0.1
                 Second          122.3 ± 0.3     69.6 ± 0.2
                 Third           126.4 ± 0.4     70.7 ± 0.4
                 *p* for trend   \<0.001         \<0.001
  Boys           First           111.6 ± 0.1     63.9 ± 0.1
                 Second          125.1 ± 0.4     68.5 ± 0.3
                 Third           129.3 ± 0.5     69.2 ± 0.4
                 *p* for trend   \<0.001         \<0.001
  Girls          First           107.5 ± 0.2     64.7 ± 0.1
                 Second          119.6 ± 0.5     70.6 ± 0.4
                 Third           123.6 ± 0.8     72.1 ± 0.6
                 *p* for trend   \<0.001         \<0.001
  6--11 years    First           107.2 ± 0.2     63.7 ± 0.1
                 Second          118.7 ± 0.5     69.0 ± 0.4
                 Third           119.9 ± 0.8     69.9 ± 0.6
                 *p* for trend   \<0.001         \<0.001
  12--17 years   First           111.8 ± 0.2     64.8 ± 0.1
                 Second          125.7 ± 0.4     69.2 ± 0.3
                 Third           130.4 ± 0.6     71.1 ± 0.5
                 *p* for trend   \<0.001         \<0.001

*Data are shown as mean ± standard error*.

*Covariance analysis adjusted for sex, age, and BMI*.

###### 

Prevalence of elevated blood pressure across three different visits by sex and age.

                **Visit**       **Elevated SBP**   **Elevated DBP**   **Elevated BP**
  ------------- --------------- ------------------ ------------------ -----------------
  Total         First           15.3               6.0                17.2
                Second          8.2                2.5                8.6
                Third           4.8                1.2                4.9
                *p* for trend   \<0.001            \<0.001            \<0.001
  Boys          First           19.1               5.8                20.6
                Second          10.9               2.5                11.2
                Third           6.6                1.2                6.7
                *p* for trend   \<0.001            \<0.001            \<0.001
  Girls         First           11.2               6.1                13.6
                Second          5.2                2.4                5.8
                Third           2.8                1.3                2.9
                *p* for trend   \<0.001            \<0.001            \<0.001
  6-11 years    First           13.1               5.4                14.7
                Second          6.7                2.3                7.0
                Third           3.7                1.0                3.9
                *p* for trend   \<0.001            \<0.001            \<0.001
  12-17 years   First           17.4               6.5                19.6
                Second          9.5                2.6                10.1
                Third           5.8                1.4                5.9
                *p* for trend   \<0.001            \<0.001            \<0.001

*Data are shown as percentages (%)*.

Elevated BP was significantly more prevalent in boys than girls during each visit (first: 20.6 vs. 13.6%, second: 11.2 vs. 5.8% and third: 6.7 vs. 2.9%). Elevated BP was also more prevalent in adolescents aged 12--17 years compared with children aged 6--11 years, with the prevalence of 19.6 vs.14.7%, 10.1 vs. 7.0%, and 5.9 vs. 3.9% at the first, second and third visit, respectively ([Table 3](#T3){ref-type="table"}).

Associations Between Obesity and Elevated BP
--------------------------------------------

[Table 4](#T4){ref-type="table"} shows the associations of general and central obesity with elevated BP across three different visits. Obesity was an independent risk factor for elevated BP at each visit, irrespective of anthropometric indices used to define weight status. Based on the BMI definition, obesity was associated with higher risk of elevated BP, with the adjusted ORs (95% CIs) being 8.6 (6.8--11.0), 12.5 (9.1--17.3), and 14.0 (8.9--22.2), respectively, across the three visits. Corresponding values were 5.7 (4.6--7.2), 7.7 (5.6--10.6), and 10.9 (6.7--17.9), respectively, for the WC definition, and 4.9 (3.9--6.1), 6.3 (4.8--8.3), and 7.7 (5.3--11.1), respectively, for the WHtR definition.

###### 

Associations of different adiposity measures with elevated blood pressure across three different visits.

                                         **First visit**   **Second visit**   **Third visit**                                 
  ----------------- -------------------- ----------------- ------------------ ------------------ --------- ------------------ ---------
  BMI categories    Normal               1                                    1                            1                  
                    Overweight           2.5 (1.9--3.2)    \<0.001            2.5 (1.7--3.6)     \<0.001   2.9 (1.7--5.1)     \<0.001
                    Obesity              8.6 (6.8--11.0)   \<0.001            12.5 (9.1--17.3)   \<0.001   14.0 (8.9--22.2)   \<0.001
  WC categories     Normal WC            1                                    1                            1                  
                    Central overweight   1.8 (1.4--2.4)    \<0.001            1.8 (1.2--2.8)     \<0.001   2.6 (1.4--4.9)     \<0.001
                    Central obesity      5.7 (4.6--7.2)    \<0.001            7.7 (5.6--10.6)    \<0.001   10.9 (6.7--17.9)   \<0.001
  WHtR categories   Normal WHtR          1                                    1                            1                  
                    Central obesity      4.9 (3.9--6.1)    \<0.001            6.3 (4.8--8.3)     \<0.001   7.7 (5.3--11.1)    \<0.001

*Adjusted for age, sex, birth weight, puberty, family history of hypertension (father, mother), and parental education levels*.

Discussion {#s4}
==========

Our study shows that the prevalence of pediatric elevated BP decreases substantially across three visits, from 17.2% at the first visit to 4.9% at the third visit. This trend might be explained by the "white-coat" effects ([@B17], [@B18]), or anxiety ([@B19]) that can result in increased BP levels. As children became more familiar with BP measurements from the first visit to the third visit, the BP measurements became more reliable. Thus, BP measured at the third visit might better reflect the true BP status of the children.

Previous studies have also reported substantial decreases in the prevalence of elevated BP in children across different visits. A study conducted in Switzerland showed that the prevalence of elevated BP was 11.4, 3.8, and 2.2%, respectively, at the first, second and third visit ([@B8]). Another study in Chinese pediatric population reported that the prevalence of elevated BP was more than halved between the first and third visit (18.2 vs. 3.1%) ([@B9]). A recent meta-analysis demonstrated that the prevalence of pediatric elevated BP decreased from 12.1% at the first visit to 2.7% at the third visit ([@B7]). The findings above are similar with our study. BP screening based on one occasional visit may mislabel a substantial number of children as hypertensive ones, which may lead to unnecessary stress for children/parents. Additionally, the Cardiovascular Risk in Young Study reported that repeated observations of elevated BP among children and adolescents enhanced the prediction of hypertension in adults ([@B20]). Altogether, these findings emphasized the necessity of BP measurements on at least three different occasions to estimate the true prevalence of hypertension in the pediatric population or to diagnose hypertension in clinical practice.

Boys had higher prevalence of elevated BP than girls in our study, which was similar to several previous studies ([@B21], [@B22]). Data from the Victorian Family Heart Study showed that estrogen receptors (ER)-alpha and ER-beta might play more important roles in the genetic regulation of BP in men, and the sex steroid-related genes may contribute to the observed sex differences in BP ([@B23]). In addition, boys were more likely to have adverse healthy behaviors \[e.g., tobacco smoking ([@B24]), alcohol use ([@B25]) and sedentary behaviors ([@B26])\] than girls. Moreover, the prevalence of elevated BP was much higher in adolescents than in children, which was consistent with several previous studies ([@B27], [@B28]). Possible explanations for the age differences included intense hormonal changes and elevated insulin resistance during pubertal period, and a much higher prevalence of overweight and obesity in adolescents vs. children in the present study.

The study also presented that adiposity was an independent risk factor for elevated BP in children, similar with previous publications ([@B8], [@B9], [@B29]). The novelty of our study includes the use of different adiposity measures to define obesity. BMI is a widely used indicator of obesity, but it cannot distinguish fat distribution. WC and WHtR are indicators of abdominal obesity that can better assess the distribution of the visceral adipose tissue. The link between obesity and hypertension may be mediated partly by the hyperactivity of the sympathetic nervous system (SNS) ([@B30], [@B31]). In children, SNS can cause a hyperdynamic hemodynamic state ([@B32]), contributing to elevated BP. Obese children with elevated BP often have increased heart rate and BP variability, which also suggests a primary role of heightened SNS activity in the association between obesity and hypertension ([@B33]).

The major strengths of our study include the large sample size, a fair participation rate (first visit: 99.8%; second visit: 91.6%; third visit: 85.3%), and the well-standardized BP measurements. However, our study also has some limitations. First, BP re-assessments were only made in children who had elevated BP readings at the initial visit. Consequently, this may cause some underestimation in hypertension, especially when some children have normal BP at first visit, but may actually have an elevated BP (i.e., masked hypertension) at the subsequent visits. Second, we used the Chinese children and adolescents BP references ([@B13]) to define elevated BP across three visits, which made our results incomparable with others. Third, our data were collected using a convenient cluster sampling method in urban area of Jinan, China, thus, the generalizability of our results to the whole Chinese children might be limited. Finally, based on a cross-sectional study design, our study is unable to provide causal associations between adiposity and pediatric elevated BP, but reverse causation is unlikely.

Conclusions {#s5}
===========

The current study demonstrates that the prevalence of elevated BP decreases substantially across three different visits, and the true prevalence of hypertension is about \~5% in Chinese children and adolescents. Our findings highlight the importance of repeated BP assessments over at least three visits before making a final diagnosis of pediatric hypertension. In addition, early accurate detection and effective control of hypertension in children should be emphasized, especially among those with excess body weight.

Data Availability {#s6}
=================

The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.

Ethics Statement {#s7}
================

All subjects gave written informed consent in accordance with the Declaration of Helsinki. Signed informed consent was obtained from all students and their guardians. Ethical approval was obtained from the Ethics Committee of the Capital Institute of Pediatrics in Beijing, China.

Author Contributions {#s8}
====================

QZ, LY, and BX conceptualized the study and drafted the article. QZ, LY, and YZ analyzed the data. YZ, MZ, YL, and BX revised the manuscript. All authors approved the final submitted and published versions.

Conflict of Interest Statement
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

We gratefully acknowledge Dr. Jie Mi from Capital Institute of Pediatrics in Beijing, China for supporting this study. We also thank the participated students and their parents as well as the teachers from the selected schools.

**Funding.** The study was supported by the National Nature Science Foundation of China (81673195, 81302496) and the National Twelfth Five-Year Plan for Science and Technology Support Program (2012BAI03B03).

BMI

:   Body Mass Index

BP

:   Blood Pressure

CIs

:   Confidence Intervals

DBP

:   Diastolic Blood Pressure

ER

:   Estrogen Receptors

ORs

:   Odds Ratios

SBP

:   Systolic Blood Pressure

SNS

:   Sympathetic Nervous System

WC

:   Waist Circumference

WHtR

:   Waist-to-height Ratio.

[^1]: Edited by: Oswin Grollmuss, Université Paris-Sud, France

[^2]: Reviewed by: Yajun Chen, Sun Yat-sen University, China; Hung-kwan So, The University of Hong Kong, Hong Kong

[^3]: This article was submitted to Pediatric Cardiology, a section of the journal Frontiers in Pediatrics
